Pre-IPO Investor Conference Call

Jun 20, 2017
Posted in: Investor updates

Home » Pre-IPO Investor Conference Call

Pre-IPO Investor Conference Call

Jun 20, 2017
Posted in: Investor updates

On June 20, 2017, Imagion Biosystems President and CEO Bob Proulx provided an update and briefing on the pending Imagion Biosystems initial public offering on the Australian Securities Exchange. An audio recording of the call is now available for listening:

Corporate Update – IND for MagSense® HER2 Phase 2 Study Immediate Priority

November 14, 2024

Corporate Updates: $3M fundraising led by CPS Capital to be completed in early December Filing of IND for MagSense® HER2 Phase 2 Study Immediate Priority

Successful Placement of A$3M

October 10, 2024

Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The

[Video] Shareholder Webinar Recording | August 15, 2024

August 22, 2024

Open a copy of this presentation deck from our ASX announcement HERE. Video transcript: Mel: Good morning, everyone. Thank you for attending the investor presentation

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Pre-IPO Investor Conference Call

Pre-IPO Investor Conference Call

Related Articles

Corporate Update – IND for MagSense® HER2 Phase 2 Study Immediate Priority

Successful Placement of A$3M

[Video] Shareholder Webinar Recording | August 15, 2024

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list